human Umbilical cord blood mesenchymal stem cell therapy (Yisaier Medical Technology)

N/A

Report date: 2026/02/07 20:00:33

Base Information

Drug Namehuman Umbilical cord blood mesenchymal stem cell therapy (Yisaier Medical Technology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSyringomyelia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYisaier Medical Technology (shan xi) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYisaier Medical Technology (shan xi) Co Ltd
Inactive CompaniesN/A
Active IndicationsSyringomyelia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A